Walkability, accessibility to metro stations and retail location choice: Some evidence from the case study of Naples
F Tinessa, F Pagliara, L Biggiero, GD Veneri - Research in Transportation …, 2021 - Elsevier
… Giuseppe for both the metro stations and the pedestrian zones. Since Quartieri Spagnoli /
San Giuseppe … Also, the area of Quartieri Spagnoli / San Giuseppe is the densest in terms of …
San Giuseppe … Also, the area of Quartieri Spagnoli / San Giuseppe is the densest in terms of …
Reduced mortality and shortened ICU stay in SARS-COV-2 patients: a low PEEP strategy
…, D Meloni, F Orlando, S Ravasi, R Sonzini, G Tinessa - MedRxiv, 2020 - medrxiv.org
Background Intensive Care Unit (ICU) management of COVID-19 patients with severe
hypoxemia is associated with high mortality. We implemented a ‘care map’, as a standardized …
hypoxemia is associated with high mortality. We implemented a ‘care map’, as a standardized …
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving …
…, F Tartamella, GP Ianniello, V Tinessa… - Journal of Clinical …, 2005 - iris.unito.it
PURPOSE: To study the prognostic value for overall survival of baseline assessment of
functional status, comorbidity, and quality of life (QoL) in elderly patients with advanced non-small…
functional status, comorbidity, and quality of life (QoL) in elderly patients with advanced non-small…
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
…, F Castiglione, F Ciardiello, V Tinessa… - The Lancet …, 2022 - thelancet.com
Background Previous analyses of the GIM (Gruppo Italiano Mammella) 2 study showed that
addition of fluorouracil to epirubicin, cyclophosphamide, and paclitaxel in patients with node-…
addition of fluorouracil to epirubicin, cyclophosphamide, and paclitaxel in patients with node-…
[HTML][HTML] Weekly Docetaxel (Wd) Vs Cmf As Adjuvant Chemotherapy for Elderly Early Breast Cancer (Ebc) Patients (Pts): Final Results from the Randomised Phase 3 …
…, V Forestieri, P Gargiulo, B Daniele, V Tinessa… - Annals of …, 2014 - Elsevier
Aim: Evidence on adjuvant chemotherapy in elderly EBC pts is poor. The ELDA trial tested
whether wD is more effective than CMF (NCT00331097). Methods: EBC pts, 65 to 79 years old…
whether wD is more effective than CMF (NCT00331097). Methods: EBC pts, 65 to 79 years old…
Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial
…, A Lombardi, P Carnicelli, V Tinessa - … Journal of the …, 1996 - Wiley Online Library
BACKGROUND Lonidamine (LND) is an indazol‐carboxylic acid derivative that selectively
inhibits the energy metabolism of neoplastic cells, and increases the permeability of cell …
inhibits the energy metabolism of neoplastic cells, and increases the permeability of cell …
Everolimus plus exemestane in advanced breast cancer: safety results of the BALLET study on patients previously treated without and with chemotherapy in the …
…, M Mauro, TC Alberto, C Saverio, C Giuseppe… - The …, 2017 - academic.oup.com
Background The BALLET study was an open‐label, multicenter, expanded access study
designed to allow treatment with everolimus plus exemestane in postmenopausal women with …
designed to allow treatment with everolimus plus exemestane in postmenopausal women with …
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised …
S De Placido, C Gallo, M De Laurentiis… - The Lancet …, 2018 - thelancet.com
Background Uncertainty exists about the optimal schedule of adjuvant treatment of breast
cancer with aromatase inhibitors and, to our knowledge, no trial has directly compared the …
cancer with aromatase inhibitors and, to our knowledge, no trial has directly compared the …
[PDF][PDF] PRESENTAZIONI ORALI
CDELDPN PERSONA… - …, 2023 - events.startpromotioneventi.it
Circa il 10% dei pazienti cardiochirurgici necessita di cure postoperatorie prolungate con
degenze più lunghe in unità di terapia intensiva (TI) e peggiori esiti a lungo termine. …
degenze più lunghe in unità di terapia intensiva (TI) e peggiori esiti a lungo termine. …
Efficacy of margetuximab vs trastuzumab in patients with pretreated ERBB2-positive advanced breast cancer: a phase 3 randomized clinical trial
Importance ERRB2 (formerly HER2)–positive advanced breast cancer (ABC) remains typically
incurable with optimal treatment undefined in later lines of therapy. The chimeric antibody …
incurable with optimal treatment undefined in later lines of therapy. The chimeric antibody …
